These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

632 related items for PubMed ID: 26861297

  • 1. Generation of Potent Anti-Vascular Endothelial Growth Factor Neutralizing Antibodies from Mouse Phage Display Library for Cancer Therapy.
    Lai YD, Wu YY, Tsai YJ, Tsai YS, Lin YY, Lai SL, Huang CY, Lok YY, Hu CY, Lai JS.
    Int J Mol Sci; 2016 Feb 05; 17(2):214. PubMed ID: 26861297
    [Abstract] [Full Text] [Related]

  • 2. Inhibiting angiogenesis with human single-chain variable fragment antibody targeting VEGF.
    Hosseini H, Rajabibazl M, Ebrahimizadeh W, Dehbidi GR.
    Microvasc Res; 2015 Jan 05; 97():13-8. PubMed ID: 25250517
    [Abstract] [Full Text] [Related]

  • 3. Tailoring in vitro selection for a picomolar affinity human antibody directed against vascular endothelial growth factor receptor 2 for enhanced neutralizing activity.
    Lu D, Shen J, Vil MD, Zhang H, Jimenez X, Bohlen P, Witte L, Zhu Z.
    J Biol Chem; 2003 Oct 31; 278(44):43496-507. PubMed ID: 12917408
    [Abstract] [Full Text] [Related]

  • 4. Affinity maturation and fine functional mapping of an antibody fragment against a novel neutralizing epitope on human vascular endothelial growth factor.
    Lamdan H, Gavilondo JV, Muñoz Y, Pupo A, Huerta V, Musacchio A, Pérez L, Ayala M, Rojas G, Balint RF, Larrick JW.
    Mol Biosyst; 2013 Aug 31; 9(8):2097-106. PubMed ID: 23702826
    [Abstract] [Full Text] [Related]

  • 5. Potent anti-angiogenesis and anti-tumor activity of a novel human anti-VEGF antibody, MIL60.
    Yang J, Wang Q, Qiao C, Lin Z, Li X, Huang Y, Zhou T, Li Y, Shen B, Lv M, Feng J.
    Cell Mol Immunol; 2014 May 31; 11(3):285-93. PubMed ID: 24608894
    [Abstract] [Full Text] [Related]

  • 6. Phage-derived fully human monoclonal antibody fragments to human vascular endothelial growth factor-C block its interaction with VEGF receptor-2 and 3.
    Rinderknecht M, Villa A, Ballmer-Hofer K, Neri D, Detmar M.
    PLoS One; 2010 Aug 02; 5(8):e11941. PubMed ID: 20689828
    [Abstract] [Full Text] [Related]

  • 7. Phage-derived fully human antibody scFv fragment directed against human vascular endothelial growth factor receptor 2 blocked its interaction with VEGF.
    Zhang J, Li H, Wang X, Qi H, Miao X, Zhang T, Chen G, Wang M.
    Biotechnol Prog; 2012 Jul 02; 28(4):981-9. PubMed ID: 22581629
    [Abstract] [Full Text] [Related]

  • 8. Identification and in vitro characterization of phage-displayed VHHs targeting VEGF.
    Farajpour Z, Rahbarizadeh F, Kazemi B, Ahmadvand D, Mohaghegh M.
    J Biomol Screen; 2014 Apr 02; 19(4):547-55. PubMed ID: 24297044
    [Abstract] [Full Text] [Related]

  • 9. Tetanus Neurotoxin Neutralizing Antibodies Screened from a Human Immune scFv Antibody Phage Display Library.
    Wang H, Yu R, Fang T, Yu T, Chi X, Zhang X, Liu S, Fu L, Yu C, Chen W.
    Toxins (Basel); 2016 Sep 11; 8(9):. PubMed ID: 27626445
    [Abstract] [Full Text] [Related]

  • 10. Identification of novel neutralizing single-chain antibodies against vascular endothelial growth factor receptor 2.
    Erdag B, Balcioglu BK, Bahadir AO, Serhatli M, Kacar O, Bahar A, Seker UO, Akgun E, Ozkan A, Kilic T, Tamerler C, Baysal K.
    Biotechnol Appl Biochem; 2011 Sep 11; 58(6):412-22. PubMed ID: 22172104
    [Abstract] [Full Text] [Related]

  • 11. A nanobody directed to a functional epitope on VEGF, as a novel strategy for cancer treatment.
    Farajpour Z, Rahbarizadeh F, Kazemi B, Ahmadvand D.
    Biochem Biophys Res Commun; 2014 Mar 28; 446(1):132-6. PubMed ID: 24569074
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of human leukemia in an animal model with human antibodies directed against vascular endothelial growth factor receptor 2. Correlation between antibody affinity and biological activity.
    Zhu Z, Hattori K, Zhang H, Jimenez X, Ludwig DL, Dias S, Kussie P, Koo H, Kim HJ, Lu D, Liu M, Tejada R, Friedrich M, Bohlen P, Witte L, Rafii S.
    Leukemia; 2003 Mar 28; 17(3):604-11. PubMed ID: 12646950
    [Abstract] [Full Text] [Related]

  • 13. Development and characterization of human monoclonal antibodies that neutralize multiple TGFβ isoforms.
    Bedinger D, Lao L, Khan S, Lee S, Takeuchi T, Mirza AM.
    MAbs; 2016 Mar 28; 8(2):389-404. PubMed ID: 26563652
    [Abstract] [Full Text] [Related]

  • 14. Isolation of a novel neutralizing antibody fragment against human vascular endothelial growth factor from a phage-displayed human antibody repertoire using an epitope disturbing strategy.
    Lamdan H, Ayala M, Rojas G, Munoz Y, Morera Y, Guirola O, Chinea G, Gavilondo JV.
    J Biotechnol; 2011 Jan 20; 151(2):166-74. PubMed ID: 21167224
    [Abstract] [Full Text] [Related]

  • 15. A humanized anti-VEGF rabbit monoclonal antibody inhibits angiogenesis and blocks tumor growth in xenograft models.
    Yu Y, Lee P, Ke Y, Zhang Y, Yu Q, Lee J, Li M, Song J, Chen J, Dai J, Do Couto FJ, An Z, Zhu W, Yu GL.
    PLoS One; 2010 Feb 05; 5(2):e9072. PubMed ID: 20140208
    [Abstract] [Full Text] [Related]

  • 16. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
    Chen Y, Wiesmann C, Fuh G, Li B, Christinger HW, McKay P, de Vos AM, Lowman HB.
    J Mol Biol; 1999 Nov 05; 293(4):865-81. PubMed ID: 10543973
    [Abstract] [Full Text] [Related]

  • 17. Genetic delivery of the murine equivalent of bevacizumab (avastin), an anti-vascular endothelial growth factor monoclonal antibody, to suppress growth of human tumors in immunodeficient mice.
    Watanabe M, Boyer JL, Hackett NR, Qiu J, Crystal RG.
    Hum Gene Ther; 2008 Mar 05; 19(3):300-10. PubMed ID: 18324912
    [Abstract] [Full Text] [Related]

  • 18. Mimotope vaccination for epitope-specific induction of anti-VEGF antibodies.
    Li W, Ran Y, Li M, Zhang K, Qin X, Xue X, Zhang C, Hao Q, Zhang W, Zhang Y.
    BMC Biotechnol; 2013 Sep 27; 13():77. PubMed ID: 24073737
    [Abstract] [Full Text] [Related]

  • 19. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
    Bae DG, Kim TD, Li G, Yoon WH, Chae CB.
    Clin Cancer Res; 2005 Apr 01; 11(7):2651-61. PubMed ID: 15814646
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of Endothelial SCUBE2 (Signal Peptide-CUB-EGF Domain-Containing Protein 2), a Novel VEGFR2 (Vascular Endothelial Growth Factor Receptor 2) Coreceptor, Suppresses Tumor Angiogenesis.
    Lin YC, Liu CY, Kannagi R, Yang RB.
    Arterioscler Thromb Vasc Biol; 2018 May 01; 38(5):1202-1215. PubMed ID: 29545238
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.